Healthcare -
Biotechnology - NASDAQ - US
$ 4.16
-11.7 %
$ 86.5 M
Market Cap
-0.7
P/E
ADVM - OPERATING INCOME
Operating Income ADVM - Adverum Biotechnologies, Inc.
-124 M
LAST VALUE
7.88%
2 YEAR CAGR
-9.69%
5 YEAR CAGR
-43.06%
10 YEAR CAGR